|
1
|
inhibitors of the renin-angiotensin-aldosterone system (RAAS; ACE-I or ARB or Renin-Inhibitors [RI]), calcium channel blockers, β-blockers or thiazides or a combination of these drugs
|
Arterial hypertension with BP above target (systolic BP >140 mmHg in multiple or 24 h-measurements or >160 mmHg in single measurement)
|
|
2
|
Metformin
|
Diabetes mellitus type 2 (HbA1c >53 mmol/mol (7%))
|
|
3
|
β-blocker
|
Chronic heart failure (any stage)
|
|
4
|
RAAS-I
|
Chronic heart failure (any stage)
|
|
5
|
Aldosterone antagonist
|
Chronic heart failure, NYHA-stage III or IV
|
|
6
|
Oral anticoagulation
|
Atrial fibrillation
|
|
7
|
Statin
|
Any cardiovascular disease (coronary heart disease, cerebrovascular disease, peripheral vascular disease)
|
|
8
|
Platelet aggregation inhibitor
|
Any cardiovascular disease
|
|
9
|
β-blocker
|
History of myocardial infarction
|
